Remove 2000 Remove angel investing Remove venture capital
article thumbnail

What Angel Investing & Florida Condos Have in Common

Both Sides of the Table

And so it happened that between 2000-2008 I was the biggest buzz kill at dinner parties. The dinner parties now are filled with self-righteous angel investors bragging about how many deals they are in on. They have marked-up paper gains propped up by an over excited venture capital market that has validated their investments.

article thumbnail

Venture Capital Q&A Session

Both Sides of the Table

We received so much positive feedback from our This Week in Venture Capital show walking through valuation calculations & term sheets that we decided to do a Q&A show this week to address topics that entrepreneurs want to learn about. In fact, far better if you haven’t raised venture capital.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

5 Good Reasons Not to Seek Angel Investment

Gust

Assume you have the right factors to get angel investment: experienced team, good product-market fit, growth potential, defensibility, and a reasonable shot at a successful exit. This might seem awkward on this site, suggesting that you don’t want angel investment. But angel investment isn’t for everybody.

article thumbnail

Turning the Camera on Chris Dixon

Both Sides of the Table

This week I sat down with Chris Dixon, co-founder / CEO of Hunch and Partner at Founder Collective in the most recent installment of This Week in Venture Capital. The firm focuses on early stage companies in the Northeast but occasionally invests in California startups.

article thumbnail

Angel Investors Do Make Money, Data Shows 2.5x Returns Overall

Gust

I began studying angel investing returns about 10 years ago as a result of a problem I couldn’t resolve: The investing world seemed certain that angel investors were rubes. Conventional wisdom dictated that they made reckless investments in very early-stage ventures mostly doomed to fail. So which is it?

article thumbnail

TechCrunch+ roundup: Non-dilutive biotech capital, long-term angel investing, WayRay’s $80M pitch deck

TechCrunch

Alomar, who led startups through the dotcom bust of 2000 and the Great Recession of 2008, will talk about whether investors are still prioritizing growth over profits, and identify which proof points founding teams must define before their next raise. 3 tips for biotech startups seeking non-dilutive capital to weather the downturn.

article thumbnail

This Week in VC Episode 6 with @Jason Calacanis: Best One Yet

Both Sides of the Table

Next Wednesday we’ll have Dana Settle of Greycroft Partners, a New York / LA early-stage venture capital fund. We spoke about the changes to an “accredited investor&# proposed by Chris Dodd – This would be bad for angel investing. Invidi is based in New York and founded in 2000. Short answer: no.

VC 285